Pharma Companies Are Suspending Trials In Russia – But For Practical More Than Ethical Reasons

 
• By Andrew McConaghie

While pharma is keen to condemn Russia’s aggression, suspension of trials is driven by logistical considerations; US FDA said it stands ready to assist sponsors of disrupted trials in Russia and Ukraine to help ensure the safety of trial participants and integrity of the studies.

Kyiv Medical Supplies March 2022
Medical supplies at a territorial defense unit in Kyiv, Ukraine, 17 March. Pharma has resisted calls to stop medicines supplies to Russia, but the conflict and sanctions have forced many to halt trials in both Ukraine and Russia. • Source: Getty Images

More from Clinical Trials

More from R&D